HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AB&B BIO-TECH-B

40.600

-0.860-2.07%

Volume:162.60K

Turnover:6.70M

Market Cap:15.97B

PE:-51.61

High:42.000

Open:41.500

Low:40.320

Close:41.460

52wk High:59.600

52wk Low:33.000

Shares:393.44M

HK Float Shares:296.36M

Volume Ratio:0.92

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.787

ROE:--

ROA:--

PB:433.56

PE(LYR):-51.61

PS:45.07

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Ab&B Bio-Tech (2627) Announces Commencement of Phase I Clinical Trials for Influenza Vaccines

Bulletin Express

AB&B BIO-TECH-B (02627) Initiates Phase I Clinical Trials for Quadrivalent and Trivalent Influenza Subunit Vaccines (Adjuvanted)

AB&B Bio-Tech Launches Phase I Trial for Adjuvanted Influenza Vaccines

AB&B BIO-TECH-B (02627) Leads the Way in Influenza Vaccines, Poised to Address Unmet Needs in Maternal and Infant Immunization

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02627"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"AB&B BIO-TECH-B","latestPrice":40.6,"timestamp":1763021314359,"preClose":41.46,"halted":0,"volume":162600,"delay":0,"floatShares":296361845,"shares":393442600,"eps":-0.7866688572272257,"marketStatus":"Not Yet Opened","change":-0.86,"latestTime":"11-13 16:08:34","open":41.5,"high":42,"low":40.32,"amount":6695978,"amplitude":0.040521,"askPrice":41.3,"askSize":2000,"bidPrice":40.6,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.6824076350214084,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763083800000},"marketStatusCode":0,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":41.46,"openAndCloseTimeList":[[1762997400000,1763006400000],[1763010000000,1763020800000]],"volumeRatio":0.9243573269461083,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.786669,"volumeRatio":0.9243573269461083,"shares":393442600,"dividePrice":0,"high":42,"amplitude":0.040521,"preClose":41.46,"low":40.32,"week52Low":33,"pbRate":"433.56","psRate":"45.07","week52High":59.6,"institutionHeld":0,"latestPrice":40.6,"committee":-0.666667,"eps":-0.7866688572272257,"divideRate":0,"volume":162600,"delay":0,"ttmEps":-0.6824076350214084,"open":41.5,"prevYearClose":12.9,"prevWeekClose":40.5,"prevMonthClose":40.3,"prevQuarterClose":49.3,"fiveDayClose":40,"twentyDayClose":44.9,"sixtyDayClose":53.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2025-11-13","current":-59.495231,"percent":0.621212,"low":-83.59026,"twenty":-76.940683,"median":-66.554289,"eighty":-63.514146,"high":-18.07815,"avg":-68.00407,"sd":9.790665,"marketCap":15973769560},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-17","current":-70.044793,"twenty":-77.841467,"median":-68.315951,"eighty":-62.332762,"marketCap":17146228508},{"date":"2025-10-24","current":-70.694139,"twenty":-77.356453,"median":-69.86748,"eighty":-62.632094,"marketCap":17311474400},{"date":"2025-10-31","current":-64.652972,"twenty":-77.130506,"median":-68.586563,"eighty":-62.679826,"marketCap":15855736780},{"date":"2025-11-07","current":-65.014442,"twenty":-77.0495,"median":-67.012733,"eighty":-63.012535,"marketCap":15934425300},{"date":"2025-11-13","current":-64.99081,"twenty":-76.940683,"median":-66.554289,"eighty":-63.514146,"marketCap":15973769560}],"updateTime":1763079530237},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178407621","title":"Ab&B Bio-Tech (2627) Announces Commencement of Phase I Clinical Trials for Influenza Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1178407621","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178407621?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:42","pubTimestamp":1763023341,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS (2627) has initiated Phase I clinical trials of its adjuvanted quadrivalent subunit influenza vaccine and adjuvanted trivalent subunit influenza vaccine. According to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"1119410585","title":"AB&B BIO-TECH-B (02627) Initiates Phase I Clinical Trials for Quadrivalent and Trivalent Influenza Subunit Vaccines (Adjuvanted)","url":"https://stock-news.laohu8.com/highlight/detail?id=1119410585","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119410585?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:42","pubTimestamp":1763023335,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced the initiation of Phase I clinical trials for its quadrivalent influenza virus subunit vaccine (adjuvanted) and trivalent influenza virus subunit vaccine...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627","159646"],"gpt_icon":0},{"id":"2583554708","title":"AB&B Bio-Tech Launches Phase I Trial for Adjuvanted Influenza Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583554708?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:33","pubTimestamp":1763022798,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech Co. Ltd. JS has announced the commencement of Phase I clinical trials for its adjuvanted quadrivalent subunit influenza vaccine and adjuvanted trivalent subunit influenza vaccine. The company recently received Investigational New Drug approvals from the National Medical Products Administration of the People's Republic of China for these vaccine candidates. No results from these clinical trials have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLQ1Rjz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"gpt_icon":0},{"id":"1109814019","title":"AB&B BIO-TECH-B (02627) Leads the Way in Influenza Vaccines, Poised to Address Unmet Needs in Maternal and Infant Immunization","url":"https://stock-news.laohu8.com/highlight/detail?id=1109814019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109814019?lang=en_us&edition=fundamental","pubTime":"2025-11-06 12:02","pubTimestamp":1762401771,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has recently achieved significant milestones. The company’s flagship product—China’s only quadrivalent influenza subunit vaccine covering all age groups—has once again been...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159646","02627"],"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02627\",params:#limit:6,delay:false,,,undefined,":[]}}